Insider Trading & Ownership of Srinivas Akkaraju

Location
Palo Alto, CA
Summary
The estimated net worth of Srinivas Akkaraju is at least $395,607,856 dollars as of 13 Jan 2026. Srinivas Akkaraju is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $101.37M. Srinivas Akkaraju is the Director of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $76.4M. Srinivas Akkaraju is the Director of ALUMIS INC. and owns shares of ALUMIS INC. (ALMS) stock worth about $75.35M. Srinivas Akkaraju is the Director, 10%+ Owner of Kalaris Therapeutics, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $73.04M. Srinivas Akkaraju is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $69.43M. Srinivas Akkaraju is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. stock worth about $20.1K.
Signature
/s/ Srinivas Akkaraju
All Insider Reports
All Insider Reports

Notify me when Srinivas Akkaraju files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Srinivas Akkaraju

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MLYS Mineralys Therapeutics, Inc. Director $101,372,213 +$23,099,993 +30% 04 Sep 2025
VTVT vTv Therapeutics Inc. Director $76,395,257 22 Sep 2025
ALMS ALUMIS INC. Director $75,349,039 +$20,546,799 +37% 09 Jan 2026
KLRS Kalaris Therapeutics, Inc. Director, 10%+ Owner $73,041,770 22 Dec 2025
SRRK Scholar Rock Holding Corp Director $69,429,463 +$19,988,986 +40% 07 Oct 2025
SYRS Syros Pharmaceuticals, Inc. Director $20,114 16 Sep 2024
KDNY CHINOOK THERAPEUTICS, INC. Director 11 Aug 2023
ICPT INTERCEPT PHARMACEUTICALS, INC. Director 08 Nov 2023
JYAC Jiya Acquisition Corp. Director, 10%+ Owner 23 Sep 2022

Insider Transactions Reported by Srinivas Akkaraju:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.